首页行业分类医疗医药医药2023-04-18-西南证券-国邦医药-产品优质矩阵丰富，品类拓展业绩提升
私信

热门文档

相关合集

快递最后一公里配送模式

2026-08-1124份文档

钻石/天然钻石/培育钻石

2026-08-10134份文档

足球产业/体育赛事

2026-10-3139份文档

租车

2026-08-1143份文档

PDF

2023-04-18-西南证券-国邦医药-产品优质矩阵丰富，品类拓展业绩提升

2023-04-18我*****84页1.14M

下载文档收藏文档
请阅读并同意免责条款
违规举报用手机查看分享文档 转换为Word/PPT
下载文档
/4
全屏查看
2023-04-18-西南证券-国邦医药-产品优质矩阵丰富，品类拓展业绩提升
还有 4 页未读 ，您可以 继续阅读 或 下载文档
下载文档 继续在线阅读
下载提示文本预览
报告派所有资源均由用户上传分享，仅供网友学习交流，未经上传用户书面授权，请勿作商用。
1、本文档共计 4 页，下载后文档不带水印，支持完整阅读内容或进行编辑。
2、当您下载文档后，并不意味着拥有了版权，文档仅供网友学习交流，不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！
4、本本所有内容不构成任何投资建议，不具有任何指导和买卖意见。
5、如文档内容存在违规，或者侵犯商业秘密、侵犯著作权等，请点击“违规举报”。
国邦医药(605507)2022年报，点评2022A2023E2024E2025E2022A2023E2024E2025E5720.927281.278811.2910702.36920.621147.791390.011662.91营业成本4144.885267.706316.217650.80折旧与摊销261.71403.48437.10456.29营业税金及册加33.0941.5950.5461.3068.01-23.766.4360.62销售货用64.1580.09105.74128.4327.71-5.00-10.00-10.00293.11604.35748.96909.70经营营运黄本变动349.21388.41301.92.392.89财务货用-68.01-23.766.4360.62其他-418.7927.130.087.32-27.71-5.00-10.00.10.001017.031161.231521.711784.2519.545.005.005.00.702.35-50.00-50.00-50.004.562.002.002.00290.5968.1645.19-19.06其他经营损益0.000.000.000.00-411.76-118.16-4.81-69.061052.881323.301600.411908.51短期借款495.40655.570.000.00-17.24-1.40-2.41-2.080.000.000.000.001035.641321.901597.991906.440.040.000.000.00所得税115.02174.11207.98243.52支付股利-111.760.000.000.00920.621147.791390.011662.91-16.7223.76-6.43-60.62-0.2841.6420.1727.70366.95631.81-6.43-60.62920.901106.151369.841635.211007.49411.261510.471654.572022A2023E2024E2025E2022A2023E2024E2025E1973.992385.253895.725550.29成长能力应收和预付款项727.581116.651362.151596.1926.98%27.27%21.01%21.46%存货1409.201929.352256.582762.1330.18%25.68%20.94%19.25%其他流动黄产1018.541049.571021.341057.7130.36%24.68%21.10%19.63%101.37101.37101.37101.37BTDA增长率19.99%36.62%20.02%18.66%79.410.000.000.003269.062960.202617.712256.04毛利率27.55%27.65%28.32%28.51%无彩资产和开发支出370.52326.83283.14239.455.06%9.07%9.77%10.27%93.51102.58111.65120.7316.09%15.76%15.78%15.54%9043.189971.8011649.6713683.90ROE12.87%13.82%14.34%14.64%655.570.000.000.00ROA10.18%11.51%11.93%12.15%1087.411557.901832.392180.83ROIC18.39%22.23%27.33%33.34%长期借款0.000.000.000.0021.79%23.39%23.20%22.66%145.60111.51124.87147.751888.581669.411957.262328.580.690.770.820.84股本558.82558.82558.82558.822.722.963.624.793607.483607.483607.483607.4810.069.969.949.87留存收益2988.954095.105464.947100.15存货周转率3.013.143.003.047155.268261.409631.2411266.4649.43%-0.6540.9961.1688.867154.618302.399692.4011355.3220.88%16.74%16.80%17.02%9043.189971.8011649.6713683.90带息债务感负债34.71%0.00%0.00%0.00%流动比率2.753.944.424.762022A2023E2024E2025E速动比率2.002.773.253.56EBITDA1246.581703.022043.952425.42股利支付率12.14%0.00%0.00%0.00%PE15.1312.5910.178.521.951.681.441.231.651.982.452.93PS2441.911.581.3012.8014.8617.3420.32EV/EBITDA9.206.164.413.02每股经营现金1.822.082.723.190.80%0.00%0.00%0.00%每股股利0.200.000.000.00请务必阅读正文后的重要声明部分